|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Antimicrobial activity of spices显示文摘 | Daljit S A Jasleen K | 1999 | International Journal of Antimicrobial Agents1999，，12： | 1 |
| 2 | Clinical profile of levobupivaeaine in regional anesthesia: A systematic review显示文摘 | Sukhminder J S B Jasleen K | 2013 | J Anaesthesiol Clin Pharmacol2013，29，4： | 1 |
| 3 | Neutrophils, not complement, mediate the mortality of experimental hemorrhagic pancreatitis显示文摘 | Kyriakides C Jasleen J Wang Y | 2001 | Pancreas2001，22，1： | 1 |
| 4 | An insight into the role of citrus bioactives in modulation of colon cancer显示文摘 | Jasleen Kaur Gurpreet Kaur | 2015 | Journal of Functional Foods2015，，： | 1 |
| 5 | Neutrophils, not complement, mediate the mortality of experimental hemorrhag-ic pancreatitis显示文摘 | Kyriakides C Jasleen J WANG Y | | 0，，： | 1 |
| 6 | Neutrophils, not com- plement, mediate the mortality of experimental hemorrhagic pancreatitis显示文摘 | Kyriakides C Jasleen J Wang Y | 2001 | Pancreas2001，22，1： | 1 |
| 7 | Signaling mechanisms of glucagon-like peptide 2-induced intestinal epithelial cell proliferation显示文摘 | Jasleen J Shimoda N Shen E R | 2000 | J Surg Res2000，90，1： | 1 |
| 8 | Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: A meta-analysis显示文摘 | Sarabjeet Singh Jasleen Duggal Janos Molnar Frank Maldonado Charles P. Barsano Rohit Arora | 2007 | International Journal of Cardiology2007，，： | 1 |
| 9 | Generalized stochastic performance models for loss-based congestion control显示文摘 | MICHELE C W LI C JASLEEN K | 2010 | Computer Communications2010，33，4： | 1 |
| 10 | Neutrophils,not complement,mediate the mortality of experimental hemorrhagic pancreatitis 显示文摘 | Kyriakides C Jasleen J Wang Y | 2001 | Pancreas2001，22，： | 1 |
| 11 | Neutrophils, not complement,mediate the mortality of experimental hemorrhage pancreatitis 显示文摘 | Kyriakides C Jasleen J Wang Y | 2001 | Pancreas2001，22，1： | 1 |
| 12 | Signaling mechanisms of glucagon-like peptide 2-induced intestinal epithelial cell proliferation显示文摘 | Jasleen J Shimoda N Shen ER | 2000 | J Surg Res2000，90，1： | 1 |
| 13 | Signaling mechanisms of gtucagon-hke peptide 2-induced intestinal epithelial cell proliferation 显示文摘 | Jasleen J Shimoda N Shen R | 2000 | Surg Res2000，90，： | 1 |
| 14 | Glucagon-like peptide 2 stimulates intestinal epithelial proliferation in vitro 显示文摘 | Jasleen J Ashley S W Shimoda N | 2002 | Dig Dis Sci2002，47，5： | 1 |
| 15 | Glucagon-like peptide 2 stimulates intestinal epithelial proliferation in vitro显示文摘 | Jasleen J Ashley SW Shimoda N | 2002 | Dig Dis Sci2002，47，5： | 1 |
| 16 | Neutrophils,not complement,mediate the mortality of experimental hemorrhagic pancreatitis显示文摘 | C Kyriakides J Jasleen Y Wang | 2001 | Pancreas2001，22，1： | 1 |
| 17 | Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience 显示文摘 | Amy SC Jasleen K Karl HB | 2004 | Plast Reconstr Surg2004，113，7： | 1 |
| 18 | Major depressive disorders in patients with inflammatory bowel disease and rheumatoid arthritis显示文摘BACKGROUND Various immune-mediated inflammatory diseases consisting of inflammatory bowel disease(IBD)and rheumatoid arthritis(RA),are found to have a substantial societal burden,increased healthcare costs,and progressive disability.Studies suggest that patients with vs without comorbid depression have a more significant disability,a lower likelihood of remission,and reduced adherence to therapy.Elevated interleukin(IL)-1β,tumor necrosis factor-α,and IL-6 contribute to developing depression by the impaired physiological responses to stress,resulting in increased pain,fever,fatigue,and lack thereof of interest,and thus poor long-term outcomes.This study emphasizes the timely recognition of the prevalence of major depressive disorder(MDD)in patients with RA and IBD combined,thus preventing disability.AIM To identify the prevalence level and temporal trends of depression in hospitalized IBD-RA patients.METHODS All adult hospitalized patients from January 2000 to December 2019 in the nationwide inpatient sample(NIS)were captured.The study population included all patients with a primary or secondary IBD-RA overlap disease using corresponding international classification of diseases(ICD)-9 and ICD-10 codes.IBD includes Crohn’s disease and ulcerative colitis.The study population was divided into IBD-RA without MDD(controls)and IBD-RA with MDD(cases).For group comparison between MDD vs no MDD,we used Student’s t-test for continuous variables and RaoScott Chi-square tests for categorical variables.For univariate analyses,we used logistic regression,and for multivariate analysis,we used a weighted multi-level mixed-effects model.We attested all hypotheses with two-tailed significance level of 0.05(P<0.05 was considered significant).The outcome is to examine the temporal trends and prevalence of depression in patients with IBD-RA by gender,race,and age.RESULTS A total of 133315 records were identified with IBD-RA overlap,of which 26155 patients(19.62%)had MDD.Among the IBD-RA patients,those who had MDD were younger[mean age of 56 years(SD±15)]to IBD-RA without MDD patients with a P<0.0001,more females(80%among cases vs 73%among controls)than males with a P<0.0001,frequent in the white race(79%among cases vs 73%among controls)than black race.Over the 19 years,the number of patients with MDD in IBDRA increased from 153(the year 2000)to 2880(the year 2019)in weighted NIS,representing a 1782%increase compared to the year 2000 with a P<0.001.Factors associated with higher MDD included younger age,female gender,white race,alcohol,opioids,esophageal disorders,peptic ulcer disease,chronic pancreatitis,paralysis,dementia,menopausal disorders,obesity,nutritional deficiencies,diabetes mellitus with chronic complications,and osteoarthritis.CONCLUSION There is a rise in the prevalence of depression in younger patients with IBD-RA combined compared to their counterparts.These patients are also at higher risk for the increased cost of care and poor treatment compliance.It is crucial to educate the involved clinicians to identify the early signs and symptoms of depression in patients with IBD or RA or IBD-RA combined and treat them to have a better overall prognosis. | Maryam Bilal Haider Brinda Basida Jasleen Kaur | 2023 | World Journal of Clinical Cases2023，11，4： | 0 |
| 19 | Ultimate fate of halosulfuron methyl and its effects on enzymatic and microbial activities in three differently textured soils显示文摘Halosulfuron methyl is a sulfonylurea herbicide used worldwide for weed control in sugarcane, maize, wheat, and rice production. Considering its environmental impact, this study evaluated the effects of soil type, application rate, and temperature on the dynamics of halosulfuron methyl degradation.Additionally, as soil microbes and enzymes are reliable indicators of the impacts of anthropogenic activities on soil health, the effects of halosulfuron methyl on soil enzymatic and microbial activities were also assessed. The half-life(DT50) of halosulfuron methyl varied from 9.38 to 33.77 d. Increase in temperature accelerated the degradation and DT50 varied from 14.39 to 33.77, 11.05 to 28.94, and 9.38 to 25.41 d at 5, 15, and 25?C, respectively. The metabolites of halosulfuron methyl, including halosulfuron, methyl 3-chloro-5-((4,6-dimethoxy-2-pyrimidinyl) amino)-1-methyl-1H-pyrazole-4-carboxylate,4,6-dimethoxy-2-pyrimidinamine, and methyl 3-chloro-1-methyl-5-sulfamoyl-1H-pyrazole-4-carboxylate, were detected in the studied soils, and their appearance and disappearance varied with application rate, soil type, and incubation temperature. Halosulfuron methyl had transitory harmful effects on soil enzymatic and microbial activities depending on its application rate. The results suggest that the application rate of halosulfuron methyl, soil physicochemical parameters, and temperature should be considered together to ensure satisfactory weed control with reduced environmental risk. | Pervinder KAUR Jasleen KAUR Harshdeep KAUR | 2023 | Pedosphere2023，33，6： | 0 |
| 20 | Novel use of esophageal overtube and water flushes as a safety indicator and facilitator for the push technique in esophageal food impaction显示文摘Esophageal food impaction requires urgent endoscopic intervention either by extraction or pushing into the stomach.Due to risks of perforation,controversy exists between when to extract verses when to push the food bolus.There are no clear guidelines on when it is safe to push a food bolus;endoscopists rely on their subjective experiences and judgment.We present a case with a novel use of an esophageal overtube and water flushes to determine the safety of pushing a food bolus and facilitate passage into the stomach. | Paul P Shao Jasleen K Grewal Adam M Custer | 2020 | Discussion of Clinical Cases2020，7，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员